Bafna Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Bafna Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Bafna Pharmaceuticals Ltd.

07 Aug 2025

98.51

-4.33%

Board Meeting

Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Intimation for Meeting Scheduled On August 12, 2025

BSE India

Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Un-Audited Financial Results for the Quarter ended June 30, 2025.

pdf

Bafna Pharmaceuticals Ltd.

05 Jul 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended June 30, 2025.

pdf

Bafna Pharmaceuticals Ltd.

30 Jun 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for Sale / Disposal of Manufacturing Unit of the Company.

pdf

Bafna Pharmaceuticals Ltd.

26 Jun 2025

98.51

-4.33%

SAST

Bafna Pharmaceuticals Ltd - 532989 - Closure of Trading Window

BSE India

Intimation for Closure of Trading Window

pdf

Bafna Pharmaceuticals Ltd.

24 Jun 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - …

BSE India

We hereby inform that the Board of Directors of the Company has re-constituted the Audit Committee, Nomination-Remuneration Committee of the Board w.e.f June 25, 2025.

pdf

Bafna Pharmaceuticals Ltd.

24 Jun 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Intimation for retirement of Mr. Palamadai Krishnan Sundaresan (DIN: 06954189) as an Independent Director of the Company upon completion of his first term, with effect from June 24, 2025.

pdf

Bafna Pharmaceuticals Ltd.

24 Jun 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Retirement

BSE India

Intimation for retirement of Mr. Palamadai Krishnan Sundaresan (DIN: 06954189) as an Independent Director of the Company upon completion of his first term, with effect from June 24, 2025.

pdf

Bafna Pharmaceuticals Ltd.

23 Jun 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation for appointment of Mr. Navin Kumar (DIN: 08778662) as an Additional Director (Non-Executive, Independent Director) of the Company with effect from June 23, 2025.

pdf

Bafna Pharmaceuticals Ltd.

23 Jun 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Intimation for appointment of Mr. Navin Kumar (DIN: 08778662) as an Additional Director (Non-Executive Independent Director) of the Company with effect from June 23, 2025.

pdf

Bafna Pharmaceuticals Ltd.

30 May 2025

98.51

-4.33%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We hereby enclose the Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31, 2025 published in "Business Standard" and "Makkal Kural" on May 28, 2025.

pdf

Is Bafna Pharmaceuticals Ltd. worth buying?

24 Votes:

Buy 66.67%

Sell 25.0%

Hold 8.33%